Recent research has identified a specific biological mechanism that may explain why females experience more severe ...
CHICAGO, IL - January 08, 2026 - PRESSADVANTAGE - Universal Wellness Roscoe Village provides access to advanced ...
AZoLifeSciences on MSN
Synthetic RNA platform converts viral replication into detectable cellular signals
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Plant regeneration relies on a delicate balance between stem cell renewal and differentiation, yet the evolutionary origin ...
Researchers have developed a new class of antibodies that amplify the immune system’s ability to fight cancer. By clustering ...
Biomunex's CSO, Dr. Simon Plyte, is invited to present an oral communication during the 11th Annual Oncology Innovation Forum on the 10th of January 2026 in San Francisco (USA). -- The oral ...
A nano-sized medicine boosts the anti-cancer immune response and eradicates tumors in mice. Researchers at Washington University School of Medicine in St. Louis, working with colleagues at ...
Neurodegenerative diseases, traditionally viewed as driven by neuronal decline, are increasingly recognized to involve ...
Cancer cells employ a variety of strategies to evade the immune system, and modern immunotherapies aim precisely at these ...
The therapy, A2B543, will be added as an arm to the ongoing Phase I/II EVEREST-2 trial, which is testing CAR T-cell products developed using A2's Tmod platform. According to A2, the Tmod platform ...
Using ribosome engineering (RE), researchers from Shinshu University introduced mutations affecting the protein synthesis ...
Higher levels of CD4-positive naïve T cells in patients receiving CAR T-cell therapy for multiple myeloma are associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results